Zelira Therapeutics Limited

Zelira Therapeutics Limited

ZLDAF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.38M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zelira Therapeutics LimitedZelira Therapeutics Limited-1.6-901%--0.5
$-0.12

Current Fair Value

161.1% downside

Overvalued by 161.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.38 Million
Enterprise Value$4.51 Million
Earnings per Share$-0.32
Beta0.6
Outstanding Shares11,619,133

Return

Return on Equity901.19%ROE
Return on Assets-3090.41%
Return on Invested Capital961.27%

Valuation & Multiples

P/E Ratio-1.56P/E Ratio
PEG3.13PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.2Price to Book Ratio
Enterprise Value to Revenue47.19
Enterprise Value to EBIT-0.11
Enterprise Value to Net Income-1
Total Debt to Enterprise0.47
Debt to Equity-0.48Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Zelira Therapeutics Limited

8 employees
CEO: Oludare Odumosu

Zelira Therapeutics Limited is an Australian biopharmaceutical company dedicated to the research, development, and commercialization of cannabinoid-derived therapeutic agents, aimed at treating a variety of medical conditions. The firm o...

Questions & Answers